ÈËÈéÍ·×´Áö²¡¶¾ÒýÆ𹬾±Ö×ÁöµÄ²¡Àí¹ý³Ì¼°Æä»úÖÆ

¡¡¡¡[20]MULLER F T, GIROGLOU T , SAPP M. Characterization of the DNA binding activity of the E1 and E2 proteins and the E1/E2 complex of human papillomavirus type 33 [J]. J Gen Virol, 1997, 78:911ª²915.

¡¡¡¡[21]LAIMINS L A. Regulation of transcription and regulation by human papilloamviruses [M]¡Î McCANCE D J. Human tumor viruses. Washinton, D. C.:American Society for Microbiology, 1998:201ª²223.

¡¡¡¡[22]DOSTATNI N, LAMBERT P F, SOUSA R, et al. The fuction of BPVª²1 E2 transactivation protein can act as a repressor by preventing formation of the initiation complex [J]. Genes Dev, 1991, 5:1657ª²1671.

¡¡¡¡[23]KLUMPP D J , LAIMINS L A. Differentiationª²induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1 [J]. Virology, 1999, 257:239ª²246.

¡¡¡¡[24]WARD P, COLEMAN D V, MALCOLM D B. Regulatory mechanisms of the papillomaviruses [J]. Trends Genet, 1989, 5:97ª²98.

¡¡¡¡[25]HOELEY P M. Papillomaviridae: the viruses and their replication [M]¡ÎFIELDS B N, KNIPE D M, HOWLEY PM,et al. Fields virology. 3rd ed. Philadelphia:Lippincottª²Raven Publishers, 1996: 947ª²948.

¡¡¡¡[26]RODRIGUEZ M I, FINBOW M E, ALONSO A. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+ª²ATPase can be dissociated from the E5ª²mediated epidermal growth factor receptor overactivation [J]. Oncogene, 2000, 19:3727ª²3732.

¡¡¡¡[27]FEHRMANN F, KLUMPP D J , LAIMINS L A. Human papillomavirus type 31 E5 protein suppots cell cycle progression and activates late viral functions upon epithelial differentiation [J]. J Virol, 2003, 77:2819ª²2831.

¡¡¡¡[28]HUMMEL M, HUDSON J B, LAIMINS L A. Diiferentiation induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomers [J]. J Virol, 1992, 66:6070ª²6080.

¡¡¡¡[29]WENTZENSEN N, VINOKUROV S, von KNEBEL DOEBERITZ

ÉÏÒ»Ò³  [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] ÏÂÒ»Ò³